Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: XVIVO Q4 Net Income At SEK 31.6 Million

Jan 27 (Reuters) - Xvivo Perfusion AB XVIVO.ST:

Q4 EPS SEK 1.01

Q4 EBIT SEK 36.8 MILLION

Q4 SALES SEK 226.1 MILLION

Q4 NET INCOME SEK 31.6 MILLION

BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND BE PAID FOR THE 2025 FINANCIAL YEAR AND THAT RETAINED EARNINGS BE CARRIED FORWARD

Source text: ID:nMFN2LNDsf

Further company coverage: XVIVO.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xvivo Perfusion AB

See all news